Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 27, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband Co-Founder Gareth Sheridan Returns as CEO

ORLANDO, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has announced that Company founder, Gareth Sheridan has returned as Company CEO. During the period of...
October 10, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Brand Institute Partnership
October 08, 2025 08:30 ET | Source: Nutriband Inc.

Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology

Provisional patent application
September 24, 2025 16:05 ET | Source: Nutriband Inc.

Nutriband Inc. to Present at the MicroCap Rodeo Conference

ORLANDO, Fla., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (The Company) (Nasdaq:NTRB) (Nasdaq: NTRBW), announces it will participate in the MicroCap Rodeo Conference, to be held Thursday,...
September 10, 2025 09:15 ET | Source: Nutriband Inc.

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

Q2 results
September 03, 2025 16:01 ET | Source: Nutriband Inc.

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

warrant conversion
August 11, 2025 05:00 ET | Source: Nutriband Inc.

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

Sheridan will temporarily step aside as CEO to enter the Irish Presidential Election. Company Chairman and President, Serguei Melnik will take over as interim CEO over the course of the...
August 08, 2025 08:00 ET | Source: Nutriband Inc.

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

FDA granted meeting request
July 18, 2025 09:15 ET | Source: Nutriband Inc.

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

Dividend dates reminder
July 09, 2025 08:05 ET | Source: Candel Therapeutics

Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution

NEEDHAM, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal...